Although the basis of drug resistance is multifactorial involving both tumor- and drug-related factors, overexpression of ABCB1 is the most common phenomenon employed by cancer cells to diminish the intracellular accumulation of chemotherapeutic agents, with approximately 50% of all anticancer agents used in the clinic effluxed by this transporter [43]. The gene discussed is ABCB1; the disease is cancer.